News
August 2, 2019

Regenstrief researcher explains passion for implementation science on podcast

Malaz Boustani, M.D., MPH, detailed his career journey and his work in the areas of brain care research and implementation science on the podcast Outcomes Rocket. Dr. Boustani is a research scientist at Regenstrief Institute in Indianapolis, the founding director of the Center for Health Innovation and Implementation Science and associate director of the Indiana University Center for Aging Research at Regenstrief Institute.

Dr. Boustani shared with the podcast’s host how his desire to protect his brain and the brains of his family led him into healthcare research. He explained that he expanded his career focus include implementation science because he wanted everyone to benefit from research discoveries.

During the interview, Dr. Boustani also spoke about the Indiana University School of Medicine’s graduate certificate designed to create change agents in healthcare settings around the country.

Outcomes Rocket features successful healthcare leaders and influencers. Its goal is to inspire collaborative thinking to solve problems and create solutions to make healthcare better.

Listen to the entire interview below:

Dr. Boustani is the Richard M. Fairbanks Professor in Aging Research, IU School of Medicine.

  • Dr. Malaz Boustani

Related News

infographic showing findings of study

Examining how insurance coverage shapes access to kidney transplantation

Regenstrief researchers contribute to a national study highlighting differences between Medicare Advantage and traditional Medicare  For people with kidney

Tarik Yuce, MD, Jiang Bian, PhD, Serena Guo, MD, PhD, Xing He, PhD, Yu Huang, PhD

GLP-1 medications linked to greater loss of regained weight after bariatric surgery

Study involving Regenstrief researchers uses real-world evidence to evaluate an option for managing weight recurrence  People who regain weight

image of a doctor consulting with a patient

Scalable approach could improve early detection of cognitive impairment in primary care

Regenstrief-led study evaluates how existing health data and patient-reported information could help clinicians identify individuals who need further assessmentEarly

Christopher Callahan, MD

Regenstrief Institute scientist named next president and CEO of Regenstrief Foundation 

Longtime Regenstrief investigator and former IU Center for Aging Research director will assume Foundation leadership in summer 2027.  Christopher